Trump's FDA Nominee Makary Faces Daunting Task of Overhauling Agency
2025-03-06
Reuters
President Donald Trump's nominee to lead the U.S. Food and Drug Administration (FDA), Martin Makary, is set to take on the challenging task of overhauling the agency. As the new FDA chief, Makary will need to balance the demands of the Trump administration while keeping key stakeholders, including Senator Kennedy, satisfied. With the FDA playing a critical role in public health, Makary's nomination has sparked interest in the pharmaceutical industry and healthcare sector, with many awaiting his plans for regulatory reforms and drug approval processes. Key areas of focus will include FDA regulations, pharmaceutical policy, and healthcare reform.